Top for 24 hours
J&J Brushes Off Looming Biosimilar Competition
Johnson & Johnson sought to reassure investors and analysts that lower-priced competition for one of its top-selling products won’t slow a company that posted slightly better-than-expected results in the third quarter.
|Related: "J&J Brushes Off Looming Biosimilar Competition" ↓|
|Last News ↓|